| GENE_SYMBOL |
DRUG_NAME |
Ki (nM) |
IC50 (nM) |
Kd (nM) |
EC50 (nM) |
Potency (nM) |
AC50 (nM) |
Datasource |
| ITGB3 |
1-[4-[(5S)-5-[[(2-amino-1,3-thiazole-5-carbonyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl]-3-methyl-2-oxopiperidine-3-carboxylic acid |
NA |
300000 |
NA |
NA |
NA |
NA |
TTD |
| ITGB3 |
ethyl 1-[4-[(5S)-5-[[(3-amino-4-chlorobenzoyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl]piperidine-4-carboxylate |
NA |
300000 |
NA |
NA |
NA |
NA |
TTD |
| ITGB3 |
ethyl 1-[4-[(5R)-5-[[(3-amino-4-chlorobenzoyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl]piperidine-4-carboxylate |
NA |
300000 |
NA |
NA |
NA |
NA |
TTD |
| ITGB3 |
16-Acetylamino-7-carbamoylmethyl-13-(3-guanidino-propyl)-3,3,14-trimethyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadecane-4-carboxylic acid amide |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |
| ITGB3 |
1-[4-[(5R)-5-[[(5-chlorothiophene-2-carbonyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl]piperidine-4-carboxylic acid |
NA |
300000 |
NA |
NA |
NA |
NA |
TTD |
| ITGB3 |
1-[4-[(5S)-5-[[(5-chlorothiophene-2-carbonyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl]piperidine-4-carboxylic acid |
NA |
300000 |
NA |
NA |
NA |
NA |
TTD |
| ITGB3 |
[16-Acetylamino-4-carbamoyl-13-(3-guanidino-propyl)-3,3,10-trimethyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadec-7-yl]-acetic acid |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |
| ITGB3 |
[16-Acetylamino-4-carbamoyl-13-(4-guanidino-butyl)-3,3-dimethyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadec-7-yl]-acetic acid |
NA |
385000 |
NA |
NA |
NA |
NA |
TTD |
| ITGB3 |
16-(2-Acetylamino-6-amino-hexanoylamino)-7-carboxymethyl-3,3,13-trimethyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadecane-4-carboxylic acid |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |
| ITGB3 |
H-Phe-Arg-Gly-Asp-OH |
NA |
947000 |
NA |
NA |
NA |
NA |
TTD |
| ITGB3 |
(Z)-4-(4-(4-(benzoyloxy)-3-methoxybenzylidene)-3-methyl-5-oxo-4,5-dihydropyrazol-1-yl)benzoic acid |
NA |
143100 |
NA |
NA |
NA |
NA |
BindingDB |
| ITGB3 |
[1-((S)-4-Methyl-2-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-pentanoyl)-piperidin-2-yl]-acetic acid |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |
| ITGB3 |
(S)-2-[((S)-3-Acetyl-thiazolidine-4-carbonyl)-amino]-3-[4-(2,6-dichloro-benzyloxy)-phenyl]-propionic acid |
NA |
400000|800000 |
NA |
NA |
NA |
NA |
TTD |
| ITGB5 |
Arg-Gly-Asp-Arg-Gly-Asp |
NA |
546000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| ITGB5 |
cyclo[Arg-Gly-Asp-Arg-Gly-Asp-Arg-Gly-Asp-Leu-Pro-Glu-Thr-Gly] |
NA |
380000 |
NA |
NA |
NA |
NA |
TTD |
| ITGB5 |
H-Gly-Gly-Gly-Gly-Gly-Gly-Gly-Arg-Gly-Asp-Leu-Pro-Glu-Thr-Gly-Gly-Ser-OH |
NA |
2945000 |
NA |
NA |
NA |
NA |
TTD |
| ITGB5 |
H-Gly-Gly-Gly-Gly-Arg-Gly-Asp-Arg-Gly-Asp-Leu-Pro-Glu-Thr-Gly-Gly-Ser-OH |
NA |
1733000 |
NA |
NA |
NA |
NA |
TTD |
| ITGB5 |
3-[(3S,6S,12S,38S,41S,44S)-6-(carboxymethyl)-12-[3-(diaminomethylideneamino)propyl]-38-[(1R)-1-hydroxyethyl]-3-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32,35,37,40,43-pentadecaoxo-1,4,7,10,13,16,19,22,25,28,31,34,36,39,42-pentadecazabicyclo[42.3.0]heptatetracontan-41-yl]propanoic acid |
NA |
522000 |
NA |
NA |
NA |
NA |
TTD |
| ITGB5 |
cyclo[Arg-Gly-Asp-D-Phe-Val-Cys(1)-Arg-Gly-Asp-D-Phe-Val-Cys(2)-Leu-Pro-Lys-Thr-Gly-Gly-Cys(1)-Cys(2)] |
NA |
208000 |
NA |
NA |
NA |
NA |
BindingDB |
| ITGB5 |
N-(2-(((5-Chloro-2-pyridinyl)amino)sulfonyl)phenyl)-4-(2-oxo-1(2H)-pyridinyl)benzamide |
NA |
380000 |
NA |
NA |
NA |
NA |
BindingDB |